Plus Therapeutics Inc Sustainability Reports
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the development of radiotherapeutic candidates for rare and difficult-to-treat cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300XD2PHUC73HMY31
2 reports from 2022 to 2024
Company Profile
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the development of radiotherapeutic candidates for rare and difficult-to-treat cancers.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
